Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

NCT05901545 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT05901545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05901545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Phase 1
Overall status
Recruiting
Start date
August 22, 2023
Completion date
November 30, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, recurrent head and neck squamous cell carcinoma